Skip to main content

Table 2 Clinical outcomes according to the presence of hypertension

From: Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19

Clinical outcome Total
(n = 3,788)
Hypertension
(n = 1,190)
Non-hypertension
(n = 2,598)
Unadjusted Age, sex-adjusted Multivariable adjusted
OR (95 % CI) P-value OR (95 % CI) P-value OR (95 % CI) P-value
Hospitalization 1,481 (39.1) 587 (49.3) 894 (34.4) 1.86 (1.61‒2.13) < 0.001 0.96 (0.81‒1.14) 0.634 1.15 (0.95‒1.38) 0.146
Oxygen requirement 267 (7.0) 154 (12.9) 113 (4.3) 3.27 (2.54‒4.21) < 0.001 1.24 (0.92‒1.68) 0.159 1.33 (0.96‒1.83) 0.083
Severe outcome 123 (3.2) 85 (7.1) 38 (1.5) 5.18 (3.51‒7.65) < 0.001 1.66 (1.06‒2.59) 0.026 1.67 (1.04‒2.69) 0.034
   ICU admission 55 (1.5) 38 (3.2) 17 (0.7) 5.01 (2.82‒8.91) < 0.001 2.59 (1.33‒5.05) 0.005 2.69 (1.33‒5.43) 0.006
   Ventilator care 34 (0.9) 25 (2.1) 9 (0.3) 6.17 (2.87‒13.3) < 0.001 2.50 (1.05‒5.94) 0.038 2.85 (1.18‒6.92) 0.020
   Death 83 (2.2) 61 (5.1) 22 (0.8) 6.32 (3.87‒10.3) < 0.001 1.36 (0.78‒2.36) 0.274 1.24 (0.69‒2.25) 0.473
  1. Data are presented as number (%) unless otherwise specified
  2. ICU intensive care unit, OR odds ratios, CI confidence intervals